Founded
2014
Legal Status
CIO
Leader
Mr A Kontoyannis
(i) the promotion and furtherance of scientific research. (ii) the development of more accurate means of diagnosis, improved protocols for management of patients and ultimately measures for prevention of histiocytic diseases; (iii) the provision and dissemination of information, (iv) collaboration with interested individuals and organisations.
Year ending 2025
Income & expenditure over time